- Ginseng Harvest Returns as "Appalachian Outlaws"
- Nuclear Engineer Asks How Could Five Barriers Fail at Fukushima
- OP-ED: How Prosecutors Think
- McConaughey Tweets "Long Way from 1971..."
- "American Sniper" Likely to Dominate Boxoffice Again
- WTAP-TV Asked to Leave DuPont C8 Public Meeting
- YEAR-END SPORTS OP-ED: Sports Crazy (or Just Crazy About Things That Matter Very Little)
- Happy Birthday Ketih Albee Gala included Singing, Dancing and Timeless Entertainment
- New Year's Day Hike at Ritter Park
- Second What's Next Huntington Draws Crowd to HHS
Investigator joins Marshall Institute for Interdisciplinary Research
She has a bachelor's degree in cell biology and a doctorate in cell communication in endocrinology from Aix-Marseille II University in France. She is an active member of the steering committee of the American Physiology Society's Cell and Molecular Physiology section.
Pierre's group at MIIR will explore new treatments for heart attacks and other cardiovascular conditions by studying how the dual role of this sodium-potassium pump regulates cardiac cell physiology in health and diseases.
As the institute's education coordinator, Pierre will work with Marshall academic program directors to facilitate students' access to research opportunities in the MIIR labs.
MIIR is Marshall University's key vehicle to advancing regional economic development through entrepreneurship and commercialization of scientific discoveries. Scientists at the institute are developing an intensive program of biotechnology research dedicated to producing patentable scientific breakthroughs and creating new businesses based on those discoveries.
Research at the institute is focused on a protein, the Na+, K+-ATPase, which is commonly referred to as the "sodium-potassium pump" because it controls the active transport of potassium and sodium in and out of cells. This "pump" plays a second, distinct role by directing many cellular processes in the heart, kidneys and other tissues. Through their studies to learn more about the molecular mechanisms by which this cellular signaling occurs, MIIR researchers are working to develop new treatments for cancer, heart and kidney disease.
"I am very pleased to have Dr. Pierre join us," said Dr. Zijian Xie, director of MIIR. "She fits very nicely because her skills not only complement the research and innovation strengths at the institute, but also enhance our educational mission. She brings national exposure to MIIR through her experience in student recruitment and her service to the American Physiology Society."
Pierre said, "I simply can't think of a role that could better suit my scientific and academic interests. I am thrilled by the prospect of exploring concrete applications for our research. I am also looking forward to working with my new colleagues at Marshall to build MIIR as an environment that will help further position students for success in biomedical research and entrepreneurship."For more information about MIIR, visit www.marshall.edu/miir.